Syngene expands R&D collaboration with Baxter

Syngene International Limited has announced the expansion of the scope of its R&D collaboration with Baxter Healthcare Corporation.

While the former is a leading global contract research organisation, the latter is a global healthcare company.

As part of the expansion, Syngene will set up additional infrastructure at the dedicated Baxter Global Research Center (BGRC) as well as increase the size of its scientific team working on Baxter projects. The duration of the agreement has also been extended until 2024.

Syngene and Baxter originally established the Baxter Global Research Center, a dedicated R&D center, in 2013.

According to Jonathan Hunt, Chief Executive Officer, Syngene International Limited, “We are very proud of our work with Baxter and the expansion of our collaboration. We advance excellent science at Syngene and our dedicated R&D Center business model allows us to offer integrated scientific solutions to clients.”

Image Credit :

Download Now – Special Research Report

A 110 page special research report that highlights around 580 key investments happened in the year 2018-19.

Daily Newsletter

Enter your email address:

Delivered by FeedBurner